Eric Moessinger

Eric Moessinger

Signal active

Partner

Bio

Eric joined NanoDimension in 2008 and was the first employee of NanoDimension’s Silicon Valley office. He is involved in deal sourcing, due diligence and deal structuring and focuses on NanoDimension’s life sciences investments together with Carl Pabo and Colin Walsh. He is a board member of Emulate and a board observer of Twist Bioscience, IonPath and Click Diagnostics. In addition to his investment and board roles at NanoDimension, Eric serves on the Commercialization Advisory Council for the Oregon Nanoscience and Microtechnologies Institute (ONAMI).

Previously, Eric was a consultant at Bain & Company in Zurich and San Francisco. While at Bain, Eric worked on strategy cases in healthcare, industrial goods and telecommunications and on the turn-around of an electrical component manufacturer. In addition, Eric spent eight months in Bain’s Private Equity Group.

Eric has an MS.c. from the London School of Economics and a BS/BA from the University of Florida.

Location

San Francisco, California, United States, North America

Social

Primary Organization

+ND Capital

+ND Capital

Founded

2002

Investment

57

Lead investment

20

Exits

12

Employees

11-50

Industry

Financial Services, Venture Capital, Nanotechnology

Jobs history

2

Partillion Bioscience

Board Member

Invalid date - Current

Visby Medical

Board Member

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Eric Moessinger is the Partner at +ND Capital, based in United States, North America. With a background in Financial Services, Eric Moessinger has a rich history of leadership and innovation. Eric Moessinger studied BS unknown @ University of Central Florida. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

16

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Dec 19, 2018-
Series C - Inscripta
+ND Capital
30.0M
Apr 04, 2019-
Series C - Inscripta
+ND Capital
20.0M
May 18, 2020
SQZ Biotech SQZ Biotech
Series D - SQZ Biotech
SQZ Biotech +ND Capital
65.0M
Sep 26, 2023
Partillion Bioscience Partillion Bioscience
Seed Round - Partillion Bioscience
Partillion Bioscience +ND Capital
5.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.